SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-227645
Filing Date
2023-09-01
Accepted
2023-09-01 16:11:33
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d518510ds3.htm S-3 148092
2 EX-5.1 d518510dex51.htm EX-5.1 12184
3 EX-23.1 d518510dex231.htm EX-23.1 1320
4 EX-FILING FEES d518510dexfilingfees.htm EX-FILING FEES 13913
5 GRAPHIC g518510g00a03.jpg GRAPHIC 66879
6 GRAPHIC g518510g0901003239991.jpg GRAPHIC 3253
7 GRAPHIC g518510g0901003506613.jpg GRAPHIC 1414
  Complete submission text file 0001193125-23-227645.txt   275514
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274314 | Film No.: 231232644
SIC: 2834 Pharmaceutical Preparations